Clinical Trials Logo

Clinical Trial Summary

The primary objective of this study is to evaluate the analgesic efficacy of two dose levels of DEX-IN compared with placebo, using the summed pain intensity difference over the first 48 hours (SPID48) in subjects with acute moderate to severe pain following unilateral bunionectomy.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02169336
Study type Interventional
Source Recro Pharma, Inc.
Contact
Status Terminated
Phase Phase 2
Start date June 2014
Completion date October 2014

See also
  Status Clinical Trial Phase
Completed NCT02284243 - Placebo-Controlled Evaluation of Intranasal Dexmedetomidine for Postoperative Analgesia Following Bunionectomy Surgery Phase 2
Completed NCT02720692 - Evaluation of N1539 Following Major Surgery Phase 3
Completed NCT03456141 - Multimodal Analgesic Protocol to Moderate Acute Pain
Not yet recruiting NCT05950152 - Efficacy, Safety and Tolerability Study of Meloxicam Injection in Subjects After Abdominal Surgery Phase 2
Completed NCT02675907 - Evaluation of N1539 Following Bunionectomy Surgery Phase 3
Completed NCT02678286 - Evaluation of N1539 Following Abdominoplasty Surgery Phase 3
Unknown status NCT01041313 - Memantine for Post-Operative Pain Control Phase 4
Completed NCT02540265 - Placebo-Controlled Evaluation of N1539 Following Bunionectomy Surgery Phase 2
Completed NCT03154658 - Serratus Anterior Plane Block in Patients Undergoing Mastectomy Phase 4